<--- Back to Details
First PageDocument Content
Health / Human sexuality / Sexually transmitted diseases and infections / Microbicides / Pre-exposure prophylaxis / Fixed dose combination / IPrEx / HIV / Antiretroviral drug / Medicine / Gilead Sciences / HIV/AIDS
Date: 2014-09-10 21:23:37
Health
Human sexuality
Sexually transmitted diseases and infections
Microbicides
Pre-exposure prophylaxis
Fixed dose combination
IPrEx
HIV
Antiretroviral drug
Medicine
Gilead Sciences
HIV/AIDS

CDC Fact Sheet: PrEP: A New Tool for HIV Prevention

Add to Reading List

Source URL: stacks.cdc.gov

Download Document from Source Website

File Size: 1,55 MB

Share Document on Facebook

Similar Documents

Gilead Sciences / Chemistry / HIV/AIDS / Medicine / Organofluorides / Specialty drugs / Prodrugs / Prevention of HIV/AIDS / AIDS Healthcare Foundation / Tenofovir alafenamide / Tenofovir disoproxil / Fixed-dose combination

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

DocID: 1rqYi - View Document

Gilead Sciences / Tenofovir alafenamide / Tenofovir disoproxil / Emtricitabine / Gilead / Fixed-dose combination

GENERAL CONFORMITY CERTIFICATE This is an electronically controlled document. User is responsible for verifying and using the effective version. Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that bas

DocID: 1pCJo - View Document

Gilead Sciences / Tenofovir alafenamide / Tenofovir disoproxil / Emtricitabine / Gilead / Fixed-dose combination

Microsoft Word - GOCER-028.docx

DocID: 1pkag - View Document

Gilead Sciences / Organofluorides / Specialty drugs / Tenofovir alafenamide / Cobicistat / Gilead / Emtricitabine / Tenofovir disoproxil / Elvitegravir / Fixed-dose combination

GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a reasonable testing program, the product referenced in this certificate complies with applicable regulations

DocID: 1oSag - View Document

Gilead Sciences / Chemistry / Fixed dose combination / Pharmacology / Organic chemistry / Bristol-Myers Squibb / Non-nucleoside reverse transcriptase inhibitors / Organofluorides / Tenofovir disoproxil / Efavirenz/emtricitabine/tenofovir / Tenofovir/emtricitabine / Fixed-dose combination

BMS_Gilead_Logo_FINAL.eps

DocID: 1m38a - View Document